PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 2.117
EU - Europa 1.094
AS - Asia 976
AF - Africa 213
SA - Sud America 197
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 4.604
Nazione #
US - Stati Uniti d'America 2.056
IT - Italia 534
SG - Singapore 462
CN - Cina 351
IE - Irlanda 205
BR - Brasile 177
CI - Costa d'Avorio 117
UA - Ucraina 86
DE - Germania 75
SN - Senegal 71
KR - Corea 58
CA - Canada 43
RU - Federazione Russa 42
GB - Regno Unito 36
IN - India 26
SE - Svezia 25
FI - Finlandia 20
VN - Vietnam 17
JP - Giappone 13
MX - Messico 13
FR - Francia 12
NL - Olanda 11
PL - Polonia 10
BD - Bangladesh 8
BE - Belgio 8
HK - Hong Kong 8
NG - Nigeria 8
AR - Argentina 7
ES - Italia 7
ZA - Sudafrica 6
AT - Austria 5
CH - Svizzera 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
EU - Europa 4
IQ - Iraq 4
KE - Kenya 4
MA - Marocco 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
NP - Nepal 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
JO - Giordania 2
KG - Kirghizistan 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.604
Città #
Santa Clara 440
Chandler 325
Singapore 290
Dublin 205
Catania 181
Chicago 160
Abidjan 117
Hefei 111
Jacksonville 94
Houston 86
Boardman 83
Dakar 71
Ashburn 59
Seoul 55
Dallas 51
Beijing 50
Cambridge 49
Lawrence 48
Andover 44
Civitanova Marche 36
Toronto 27
Wilmington 27
Des Moines 25
Los Angeles 25
Nanjing 23
Bremen 22
The Dalles 18
Rome 17
Columbus 16
Falls Church 16
Messina 16
Seattle 16
Council Bluffs 14
Aci Catena 13
Milan 13
Palermo 13
Munich 12
São Paulo 12
Tokyo 12
Redwood City 11
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Ottawa 10
Rio de Janeiro 10
Saint Petersburg 10
Shenyang 10
Belo Horizonte 9
Mumbai 9
San Mateo 9
Warsaw 9
Abuja 8
Brooklyn 8
Grafing 8
New York 8
Redmond 8
Jiaxing 7
Lappeenranta 7
Manchester 7
Nanchang 7
Naples 7
Rosolini 7
San Gregorio di Catania 7
Bronte 6
Dearborn 6
Guangzhou 6
Mercogliano 6
Pozzallo 6
Shanghai 6
Stockholm 6
Brasília 5
Brussels 5
Cagliari 5
Hong Kong 5
Hyderabad 5
Manaus 5
Moscow 5
Phoenix 5
Turku 5
Washington 5
Baranzate 4
Boston 4
Curitiba 4
Helsinki 4
Jinan 4
Johannesburg 4
London 4
Mexico City 4
Nairobi 4
Ningbo 4
Novara 4
Pune 4
San Francisco 4
Sumaré 4
Tianjin 4
Turin 4
Vicenza 4
Zhengzhou 4
Atlanta 3
Totale 3.275
Nome #
Current drug treatments targeting dopamine D3 receptor 178
Antioxidant and osmoprotecting activity of taurine in dry eye models 124
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 109
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 108
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 106
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 105
Caffeine Protects Against Retinal Inflammation 102
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 99
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 98
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 98
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 96
P2X7 receptor antagonism: implications in diabetic retinopathy 91
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 91
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 84
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 83
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 83
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 83
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 82
Controversies in Glaucoma: Current Medical Treatment and Drug Development 81
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 79
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 78
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 78
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 76
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 76
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 76
Retinal protection and distribution of curcumin in vitro and in vivo 76
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 74
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 73
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 71
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 71
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 71
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 70
Novel therapeutics in glaucoma management 70
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 69
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 68
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 68
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 67
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 66
Do extracellular RNAs provide insight into uveal melanoma biology? 65
Ocular allergy 64
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 64
Ocular pharmacological profile of hydrocortisone in dry eye disease 62
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 62
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 61
MicroRNA target prediction in glaucoma 59
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 59
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 59
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 58
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 57
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 56
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 56
In-Silico Characterization of von Willebrand Factor Bound to FVIII 55
Integrating network pharmacology: The next-generation approach in ocular drug discovery 55
Characterization of protein-protein interfaces through a protein contact network approach 54
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 54
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 52
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 52
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 51
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 42
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 40
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 40
The P2X7 receptor as a new pharmacological target for retinal diseases 40
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 37
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 36
Ocular Allergies 29
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 21
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 17
Totale 4.735
Categoria #
all - tutte 17.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.943


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 21 3 53 13 34 5 19 15 27 20
2021/2022403 31 45 10 8 52 25 66 23 32 6 19 86
2022/2023939 62 66 18 110 123 122 16 172 176 16 31 27
2023/2024409 32 45 18 21 31 116 7 31 1 3 57 47
2024/20251.812 43 259 84 129 379 246 106 57 134 108 155 112
2025/2026478 246 184 48 0 0 0 0 0 0 0 0 0
Totale 4.735